1 |
H. S. Park, S. W. Oh, J. H. Kang, Y. W. Park, and J. M Choi, "Prevalence and associated factors with metabolic syndrome in South Korea: from the Korean National Health and Nutrition Examination Survey, 1998," J Korean Soc Study Obes, Vol.12, pp.1-14, 2003.
|
2 |
H. Sumino, S. Ichikawa, T. Kanda, T. Nakamura, and T. Sakamaki, "Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia," Lancet, Vol.354, p.650, 1999.
DOI
|
3 |
Kap-Tae Park, In-Sik Kim, Se-Cheol Yoo, Jin-Seok Yoon, Tae-Ho Ahn, and Jung-Hwa Lee, "Relationship between Serum Uric Acid, Abdominal Obesity, and Waist Circumference in Korean," Korean J Clin Lab Sci., Vol.44, No.2, pp.39-45, 2012.
|
4 |
S. M. Grundy, "Approach to lipoprotein management in 2001 National Cholesterol Guidelines," Am J Cardiol, Vol.90, pp.11-21, 2002.
|
5 |
G. M. Reaven, "Role insulin resistance in human disease," Diabetes, Vol.37, pp.1595-1607, 1988.
DOI
|
6 |
X. Sui, T. S. Church, R. A. Meriwether, F. Lobelo, and S. N. Blair, "Uricaci d and the development of metabolic syndrome in women and men," Metabolism, Vol.57, No.6, pp.845-852, 2008.
DOI
|
7 |
R. A. DeFonzo and E. Ferrannini, "Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic carudiovascular disease," Diabetes Care, Vol.14, pp.173-194, 1991.
|
8 |
A. D. Liese, E. J. Mayer-Davis, H. A. Tyroler, C. E. Davis, U. Keil, and M. I. Schimidt, "Familial components of the multiple metabolic syndrome: the ARIC study," Diabetologia, Vol.40, pp.963-970, 1997.
DOI
|
9 |
Y. Hong, N. L. Pedersen, K. Brismar, and Y. de Faire, "Genetic and environmental architecture of the features of the insulin-resistance syndrome," Am J Genet, Vol.40, pp.963-970, 1997.
|
10 |
H. K. Choi and E. S. Ford, "Prevalence of the metabolic syndrome in individuals with yperuricemia," Am J Med, Vol.120, No.5, pp.442-447, 2007.
DOI
|
11 |
B. Alverez-Lario and J. Macarron-Vicente, "Uric acid and evolution," Rheuma-tology, Vol.49, pp.2010-2015, 2010.
DOI
|
12 |
E. P. De Oliveira and R. C. Burini, "High plasma uric acid concentration: causes and consequences," Diabetology & Metabolic syndrome, Vol.4, pp.4-12, 2012.
DOI
|
13 |
T. Nakagawa, K. R. Tuttles, R. A. Short, and R. J. Johnson, "Hypothesis: fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome," Nat Clin Pract Nephrol, Vol.1, No.2, pp.80-86, 2005.
DOI
|
14 |
K. Masuo, H. Kawaguchi, H. Mikami, T. Ogihara, and M. L. Tuck, "Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation," Hypertension, Vol.42, No.4, pp.474-480, 2003.
DOI
|
15 |
A. Dehghan, M. van Hoek, E. J. Sijbrands, A. Hofman, and J. C. Witteman, "High serum uric acid as a novel risk factor for type 2 diabetes," Diabetes Care, Vol.31, No.2, pp.361-362, 2008.
DOI
|
16 |
M. H. Alderman, H. Cohen, S. Madhavean, and K. Salah, "Serum uric acid and cardiovascular events in successfully treated hypertensive patients," Hypertension, Vol.34, No.1, pp.144-150, 1999.
DOI
|
17 |
J. V. Selby, G. D. Friedman, and C. P. Quesenberry Jr, "Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries," Am J Epidemiol, Vol.131, pp.1017-1027, 1990.
DOI
|
18 |
B. Rocic, M. Vucic-Lovrencic, N. Poje, M. Poje, and F. Bertuzzi, "Uric acid may inhibit glucose-induced insulin secretion via binding to an essential arginine residue in rat pancreatic beta-cells," Bioorg Med Chem Lett, Vol.15, No.4, pp.1181-1184, 2005.
DOI
|
19 |
R. Klein, B. E. Klein, J. C. Cornoni, J. Maready, J. C. Cassel, and H. A. Tyroler, "Serum uric acid: its relationship to coronary heart disease risk factors and cardiovascular disease in Evans County, Georgia," Ann Intern Med., Vol.132, pp.401-410, 1973.
DOI
|
20 |
H. A. Kahn, J. H. Medalie, H. N. Neufeld, E. Riss, and U. Goldbourt, "The incidence of hypertension and associated factors: the Israel ischemic heart disease study," Am Heart J., Vol.84, pp.171-182, 1972.
DOI
|
21 |
F. Jossa, E. Farinaro, S. Panico, V. Krogh, E. Celentano, and R. Galasso, "Serum uric acid and hypertension: the Olivetti heart study," J Hum Hypertens, Vol.8, pp.677-681, 1994.
|
22 |
I. Zavaroni, S. Mazza, M. Fantuzzi, E. Dall''Aglio, E. Bonora, and R. Delsignore, "Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia," J Intern Med, Vol.234, pp.25-30, 1993.
DOI
|
23 |
H. Vuorinen-Markkola and H. Yki-Jarvinen, "Hyperuricemia and insulin resistance," J Clin Endocrinol Metab, Vol.78, pp.25-29, 1994.
|
24 |
M. Cigolini, G. Targher, M. Tonoli, F. Manara, M. Muggeo, and G. De Sandre, "Hyperuricaemia: relationship to body fat distribution and other components of the insulin resistance syndrome in 38-year-old healthy men and women," Int J Obes Relat Metab Disord, Vol.19, pp.92-96, 1995.
|
25 |
M. Mazzali, J. Kanellis, L. Han, L. Feng, Y. Y. Xia, and Q. Chen, "Hyperuricemia induces a primary arteriolopathy in rats by a blood pressureindependent mechanism," Am J Physiol Renal Physiol, Vol.282, pp.F991-997, 2002.
DOI
|
26 |
C. M. Alexander, P. B. Landsman, S. M. Teutsch, and S. M. Haffner, "NCEP defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older," Diabetes, Vol.52, pp.1210-1204, 2003.
DOI
|
27 |
B. S. Cha and H. J. Kim, "Metabolic syndrome and cardiovascular disease," Korean Circ J., Vol.33, pp.645-652, 2003.
DOI
|
28 |
J. R. Sowers and M. Lester, "Diabetes and cardiovascular disease," Diabetes Care, Vol.22, Suppl.3, pp.C14-20, 1999.
|
29 |
H. J. Ward, "Uric acid as an independent risk factor in the treatment of hypertension," Lancet, Vol.352, pp.670-671, 1998.
DOI
|
30 |
M. H. Ginsberg, F. Kozin, M. O'Malley, and D. J. McCarty, "Release of platelet constituents by monosodium urate crystals," J Clin Invest, Vol.60, pp.999-1007, 1997.
|
31 |
J. G. Wheeler, K. D. M. Juzwishin, G. Eiriksdottir, V. Gudnason, and J. Danesh, "Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis," PloS Med, Vol.2, No.3, pp.236-234, 2005.
DOI
|
32 |
B. H. Solymoss, M. G. Bourassa, L. Campeau, A. Sniderman, M. Marcil, and J. Lesperance, "Effect of Increasing Metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity," Am J Cardiol, Vol.93, pp.159-164, 2004.
DOI
|
33 |
V. Regitz-Zagrosek, E. Lehmkuhl, and M. O. Weickert, "Gender differences in the metabolic syndrome and their role for cardiovascular disease," Clin Res Cardiol, Vol.95, pp.136-147, 2006.
DOI
|